153 related articles for article (PubMed ID: 30111820)
1. Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma.
Manzano M; Patil A; Waldrop A; Dave SS; Behdad A; Gottwein E
Nat Commun; 2018 Aug; 9(1):3263. PubMed ID: 30111820
[TBL] [Abstract][Full Text] [Related]
2. Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1.
Dunham D; Viswanathan P; Gill J; Manzano M
J Virol; 2022 Dec; 96(23):e0136022. PubMed ID: 36416587
[TBL] [Abstract][Full Text] [Related]
3. Druggable host gene dependencies in primary effusion lymphoma.
Kuehnle N; Gottwein E
Curr Opin Virol; 2022 Oct; 56():101270. PubMed ID: 36182745
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
J Virol; 2020 May; 94(10):. PubMed ID: 32161170
[TBL] [Abstract][Full Text] [Related]
5. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
6. CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma.
Patil A; Manzano M; Gottwein E
Blood; 2018 Aug; 132(6):577-586. PubMed ID: 29954751
[TBL] [Abstract][Full Text] [Related]
7. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
[TBL] [Abstract][Full Text] [Related]
9. KSHV-infected PEL cell lines exhibit a distinct gene expression profile.
Ueda K; Ito E; Karayama M; Ohsaki E; Nakano K; Watanabe S
Biochem Biophys Res Commun; 2010 Apr; 394(3):482-7. PubMed ID: 20175997
[TBL] [Abstract][Full Text] [Related]
10. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma.
Lam BQ; Dai L; Li L; Qiao J; Lin Z; Qin Z
Oncotarget; 2017 Mar; 8(11):18373-18380. PubMed ID: 28407694
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma.
Cao Y; Qiao J; Lin Z; Zabaleta J; Dai L; Qin Z
Oncotarget; 2017 Feb; 8(9):15220-15229. PubMed ID: 28146424
[TBL] [Abstract][Full Text] [Related]
13. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
14. Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors.
Wang C; Zhang L; Ke L; Ding W; Jiang S; Li D; Narita Y; Hou I; Liang J; Li S; Xiao H; Gottwein E; Kaye KM; Teng M; Zhao B
Nat Commun; 2020 Dec; 11(1):6318. PubMed ID: 33298918
[TBL] [Abstract][Full Text] [Related]
15. A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma.
Punj V; Matta H; Chaudhary PM
PLoS One; 2012; 7(5):e37498. PubMed ID: 22624040
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M
Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820
[TBL] [Abstract][Full Text] [Related]
17. Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
Dai L; Lin Z; Qiao J; Chen Y; Flemington EK; Qin Z
Oncogene; 2017 Aug; 36(35):5068-5074. PubMed ID: 28459467
[TBL] [Abstract][Full Text] [Related]
18. Effects of ER stress on unfolded protein responses, cell survival, and viral replication in primary effusion lymphoma.
Shigemi Z; Baba Y; Hara N; Matsuhiro J; Kagawa H; Watanabe T; Fujimuro M
Biochem Biophys Res Commun; 2016 Jan; 469(3):565-72. PubMed ID: 26692493
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
20. Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma.
Dai L; Cao Y; Chen Y; Kaleeba JA; Zabaleta J; Qin Z
Oncotarget; 2015 May; 6(14):12710-22. PubMed ID: 25860939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
